Afzaljavan, FahimehSadr, Ayeh SadatSavas, SevtapPasdar, Alireza2021-04-082021-04-082021-01-18Afzaljavan, F, Sadr, A S, Savas, S & Pasdar, A 2021, 'GATA3 somatic mutations are associated with clinicopathological features and expression profile in TCGA breast cancer patients', Scientific Reports, vol. 11, no. 1, 1679. https://doi.org/10.1038/s41598-020-80680-92045-2322ORCID: /0000-0002-7864-9729/work/93483038https://hdl.handle.net/2164/16201Acknowledgments This work was mainly conducted in a sabbatical period at the Discipline of Genetics, Faculty of Medicine, Memorial University, St. John’s, Canada (FA), with the financial support from the Mashhad University of Medical Sciences, Mashhad, Iran. Authors gratefully acknowledge the use of data generated by TCGA Research Network (https://www.cancer.gov/tcga). Funding Information: This work was financially supported by Mashhad University of Medical Sciences under grant 931185. Supplementary Information: The online version contains supplementary material available at https://doi. org/10.1038/s41598-020-80680-9.131854479engSDG 3 - Good Health and Well-beingBiomarkersCancerComputational biology and bioinformaticsGeneticsMolecular biologyOncologyRisk factorsR MedicineGeneralSupplementary DataRGATA3 somatic mutations are associated with clinicopathological features and expression profile in TCGA breast cancer patientsJournal article10.1038/s41598-020-80680-9http://www.scopus.com/inward/record.url?scp=85100104975&partnerID=8YFLogxK111